ArticleNature communications2021

Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer.

Jeremy J McGuire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.